Sana Biotechnology, Inc. Nrrtv Max Aggt Offering Pric
Sana Biotechnology, Inc. (SANA) had Nrrtv Max Aggt Offering Pric of $50.00 million as of 2026-04-13, per its 424B5 filed 2026-04-13.
Financial Statements › Notes
ffd:NrrtvMaxAggtOfferingPric · last filed 2026-04-13
- 2026-04-13: Nrrtv Max Aggt Offering Pric $50.00M.
| Period end | Nrrtv Max Aggt Offering Pric |
|---|---|
| 2026-04-13 | $50.00M 424B5 · filed 2026-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |